Variant report
Variant | nsv946494 |
---|---|
Chromosome Location | chr1:168547940-168549528 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:1)
- CpG islands (count:61)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:1 , 50 per page) page:
1
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:168549490-168549540 | Caco-2 | colon: | n/a |
2 | chr1:168549490-168549540 | HRCEpiC | kidney: | n/a |
3 | chr1:168549490-168549540 | AoSMC | blood vessel: | n/a |
4 | chr1:168549490-168549540 | NH-A | brain: | n/a |
5 | chr1:168549490-168549540 | GM12878 | blood: | n/a |
6 | chr1:168549490-168549540 | AG04450 | lung: | fetal |
7 | chr1:168549490-168549540 | SK-N-SH_RA | brain: | n/a |
8 | chr1:168549490-168549540 | GM12891 | blood: | n/a |
9 | chr1:168549490-168549540 | U87 | brain: | n/a |
10 | chr1:168549490-168549540 | HEK293 | kidney: | embryo |
11 | chr1:168549490-168549540 | HNPCEpiC | eye: | n/a |
12 | chr1:168549490-168549540 | PFSK-1 | brain: | n/a |
13 | chr1:168549490-168549540 | PrEC | prostate: | n/a |
14 | chr1:168549490-168549540 | HRE | kidney: | n/a |
15 | chr1:168549490-168549540 | AG10803 | skin: | n/a |
16 | chr1:168549490-168549540 | Jurkat | blood: | n/a |
17 | chr1:168549490-168549540 | BJ | skin: | n/a |
18 | chr1:168549490-168549540 | NHDF-neo | bronchial: | n/a |
19 | chr1:168549490-168549540 | PANC-1 | pancreas: | n/a |
20 | chr1:168549490-168549540 | GM06990 | blood: | n/a |
21 | chr1:168549490-168549540 | LNCaP | prostate: | n/a |
22 | chr1:168549490-168549540 | ovcar-3 | ovarian: | n/a |
23 | chr1:168549490-168549540 | SK-N-MC | brain: | n/a |
24 | chr1:168549490-168549540 | HCPEpiC | choroid plexus: | n/a |
25 | chr1:168549490-168549540 | HL-60 | blood: | n/a |
26 | chr1:168549490-168549540 | GM12892 | blood: | n/a |
27 | chr1:168549490-168549540 | SKMC | muscle: | n/a |
28 | chr1:168549490-168549540 | IMR90 | lung: | fetal |
29 | chr1:168549490-168549540 | RPTEC | kidney: | n/a |
30 | chr1:168549490-168549540 | A549 | lung: | n/a |
31 | chr1:168549490-168549540 | HIPEpiC | eye: | n/a |
32 | chr1:168549490-168549540 | NHBE | bronchial: | n/a |
33 | chr1:168549490-168549540 | BE2_C | brain: | n/a |
34 | chr1:168549490-168549540 | HRPEpiC | eye: | n/a |
35 | chr1:168549490-168549540 | GM19239 | blood: | n/a |
36 | chr1:168549490-168549540 | HCT-116 | colon: | n/a |
37 | chr1:168549490-168549540 | Hepatocyte | liver: | n/a |
38 | chr1:168549490-168549540 | T-47D | breast: | n/a |
39 | chr1:168549490-168549540 | SK-N-SH | brain: | n/a |
40 | chr1:168549490-168549540 | AG04449 | skin: | fetal |
41 | chr1:168549490-168549540 | HCM | heart: | n/a |
42 | chr1:168549490-168549540 | MCF10A-Er-Src | breast: | n/a |
43 | chr1:168549490-168549540 | SAEC | small airway: | n/a |
44 | chr1:168549490-168549540 | ECC-1 | luminal epithelium: | n/a |
45 | chr1:168549490-168549540 | NT2-D1 | testis: | n/a |
46 | chr1:168549490-168549540 | AG09309 | skin: | n/a |
47 | chr1:168549490-168549540 | HMEC | breast: | n/a |
48 | chr1:168549490-168549540 | HUVEC | blood vessel: | n/a |
49 | chr1:168549490-168549540 | K562 | blood: | n/a |
50 | chr1:168549490-168549540 | HEEpiC | esophagus: | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-XCL2-4 | chr1:168547891-168548677 | NONHSAT007441 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000229757 | TF binding region |
ENSG00000229757 | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2300298 | chr1:168547941-168547942 | Active TSS Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs541549563 | chr1:168547967-168547968 | Active TSS Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs560069227 | chr1:168547977-168547978 | Active TSS Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs149992571 | chr1:168547991-168547992 | Active TSS Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs2300299 | chr1:168548003-168548004 | Active TSS Enhancers Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs116039409 | chr1:168548018-168548019 | Active TSS Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs79291815 | chr1:168548113-168548114 | Active TSS Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs77736410 | chr1:168548115-168548116 | Active TSS Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs78585004 | chr1:168548131-168548132 | Active TSS Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs79499715 | chr1:168548155-168548156 | Active TSS Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs375254257 | chr1:168548159-168548160 | Active TSS Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs145173910 | chr1:168548163-168548164 | Active TSS Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs549385090 | chr1:168548165-168548166 | Active TSS Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs559877124 | chr1:168548168-168548169 | Active TSS Enhancers Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs532091453 | chr1:168548217-168548218 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs149177787 | chr1:168548224-168548225 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs566137476 | chr1:168548293-168548294 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
18 | rs7529299 | chr1:168548328-168548329 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs536886389 | chr1:168548329-168548330 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs548858609 | chr1:168548363-168548364 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs28445100 | chr1:168548372-168548373 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs570366574 | chr1:168548375-168548376 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs537407051 | chr1:168548379-168548380 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs558664306 | chr1:168548400-168548401 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs143285447 | chr1:168548417-168548418 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs534803850 | chr1:168548421-168548422 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs12738456 | chr1:168548445-168548446 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs4656156 | chr1:168548516-168548517 | Active TSS Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs12738495 | chr1:168548524-168548525 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs542414123 | chr1:168548534-168548535 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs560824834 | chr1:168548537-168548538 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs575949606 | chr1:168548564-168548565 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs4656157 | chr1:168548574-168548575 | Active TSS Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs138215901 | chr1:168548627-168548628 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs532181445 | chr1:168548633-168548634 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs114274193 | chr1:168548639-168548640 | Active TSS Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs114875062 | chr1:168548692-168548693 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs397832426 | chr1:168548699-168548700 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs111741548 | chr1:168548704-168548705 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs671345 | chr1:168548722-168548723 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs58887669 | chr1:168548728-168548729 | Active TSS Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs537717595 | chr1:168548734-168548735 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs529934 | chr1:168548738-168548739 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs529928 | chr1:168548741-168548742 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs150094470 | chr1:168548750-168548751 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs189888053 | chr1:168548753-168548754 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs193173000 | chr1:168548781-168548782 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs138379149 | chr1:168548792-168548793 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs373719664 | chr1:168548824-168548825 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs554329397 | chr1:168548833-168548834 | Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Liposarcoma | 21253554 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 21183584 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Lung cancer | 18438408 | CNVD |
Rett syndrome | 21593744 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Bladder cancer | 19088036 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Breast cancer | 21858162 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chordoma | 18071362 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Trisomy 5 syndrome | 21098271 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Breast cancer | 21611746 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Cancer | 17060936 | CNVD |
Lung cancer | 16740712 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Williams-beuren syndrome | 16971481 | CNVD |
Developmental delay | 21147756 | CNVD |
Burkitt''s lymphoma | 20823134 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21364760 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:168539400-168550600 | Weak transcription | HepG2 | liver |
2 | chr1:168546000-168549200 | Active TSS | Primary Natural Killer cells fromperipheralblood | blood |
3 | chr1:168547600-168548200 | Enhancers | Skeletal Muscle Female | skeletal muscle |
4 | chr1:168549200-168549400 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
5 | chr1:168549200-168549400 | Transcr. at gene 5' and 3' | Primary Natural Killer cells fromperipheralblood | blood |
6 | chr1:168549400-168549600 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
7 | chr1:168549400-168549800 | Genic enhancers | Primary Natural Killer cells fromperipheralblood | blood |